Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Hypoxia”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Testing effectiveness (Phase 2)Study completedNCT03054337
What this trial is testing

Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

Who this might be right for
AnemiaNon-dialysis Dependent Chronic Kidney Disease
Akebia Therapeutics 51
Not applicableStudy completedNCT02683915
What this trial is testing

Reno-protective Effect of Brain Cooling in Newborn With Hypoxia

Who this might be right for
Hypoxic Ischemic Encephalopathy
Mansoura University Children Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT07000149
What this trial is testing

Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
AstraZeneca 1,116
Large-scale testing (Phase 3)Active Not RecruitingNCT05899049
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 249
Not applicableStudy completedNCT01674465
What this trial is testing

Role of Nox2 in CNI-induced Renal Fibrosis

Who this might be right for
Kidney Disease
University of Wisconsin, Madison 8
Testing effectiveness (Phase 2)Looking for participantsNCT07049926
What this trial is testing

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 140
Not applicableUnknownNCT02979275
What this trial is testing

Correlation of Brain and Thenar Muscle Oximetry During Cardiac Surgery With Parameters of Acute Kidney Injury

Who this might be right for
Acute Kidney InjuryHeart Valve Diseases
Medical University of Gdansk 100
Testing effectiveness (Phase 2)Ended earlyNCT03140722
What this trial is testing

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06147232
What this trial is testing

Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

Who this might be right for
NephropathyDiabetic NephropathiesDiabetes Mellitus, Type 1+4 more
Steno Diabetes Center Copenhagen 69
Not applicableUnknownNCT02987179
What this trial is testing

Identification of Desaturation Episodes by Means of Continuous Measurement of Oxygen Saturation During Hemodialysis

Who this might be right for
ESRDSleep ApneaOxygen Deficiency
Renal Research Institute 30
Not applicableLooking for participantsNCT06475261
What this trial is testing

Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Oxygen DeficiencyAcute Kidney InjuryOvarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04489771
What this trial is testing

Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 154
Post-approval studies (Phase 4)UnknownNCT06115421
What this trial is testing

Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients

Who this might be right for
Anemia in Dialysis-dependent CKD Patients
Alexandria University 72
Not applicableUnknownNCT03897920
What this trial is testing

Doppler Ultrasound Renal Arterial Resistive Indices As Predictor Of Multiorgan Failure In Patients With Acute Hypoxic Respiratory Failure Admitted To Respiratory Intensive Care Unit (Cryptic Shock Index- RICU)

Who this might be right for
Respiratory FailureMulti Organ Failure
University of Modena and Reggio Emilia 30
Not applicableStudy completedNCT03433079
What this trial is testing

Acute Kidney Injury in Severe Trauma

Who this might be right for
Acute Kidney Injury
University Hospital Ostrava 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07262060
What this trial is testing

Improving Preterm Kidney Outcomes With Caffeine

Who this might be right for
Kidney InjuryPre-Term
University of Wisconsin, Madison 114
Large-scale testing (Phase 3)WithdrawnNCT03242967
What this trial is testing

Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics
Not applicableStudy completedNCT05495607
What this trial is testing

Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Who this might be right for
Hypoxic-Ischemic EncephalopathySepsisKidney Diseases+4 more
Centre Hospitalier Universitaire de Nice 25
Testing effectiveness (Phase 2)Study completedNCT02260193
What this trial is testing

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Who this might be right for
AnemiaEnd Stage Renal Disease
Akebia Therapeutics 94
Testing effectiveness (Phase 2)Ended earlyNCT05935748
What this trial is testing

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+18 more
NiKang Therapeutics, Inc. 18
Load More Results